GPT and cancer: Consistent with this, point mutation of Isocitrate Dehydrogenase 1 (IDH1) (R132H), which is frequently found to be coincident with ATRX mutations in certain cancers, including glioma [88], is sufficient to create tumorigenic cells with ALT characteristics [89].